Get the Stockscreener App
0.7772
7.20%
0.0522
After Hours:
.79
0.0128
+1.65%
Beyondspring Inc stock is traded at $0.7772, with a volume of 15,573.
It is up +7.20% in the last 24 hours and up +7.91% over the past month.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. Its first asset, Plinabulin is a novel brain-penetrant microtubule modulator with dendritic cell maturation and vasculature modulation mechanism, which has the potential to help mitigate acquired resistance from prior immune checkpoint inhibitors (ICI) treatment in cancer patients. It is a Selective Immunomodulating Microtubule-Binding Agent (SIMBA), which may provide multiple therapeutic opportunities.
See More
Previous Close:
$0.725
Open:
$0.7177
24h Volume:
15,573
Relative Volume:
0.02
Market Cap:
$31.96M
Revenue:
$1.88M
Net Income/Loss:
$-8.48M
P/E Ratio:
-4.1318
EPS:
-0.1881
Net Cash Flow:
$-19.13M
1W Performance:
+3.65%
1M Performance:
+7.91%
6M Performance:
-53.74%
1Y Performance:
-53.74%
1-Day Range:
$0.7177
$0.79
1-Week Range:
$0.712
$0.79
52-Week Range:
$0.5657
$2.44
Beyondspring Inc Stock (BYSI) Company Profile
Name
Beyondspring Inc
Sector
Industry
Phone
646-528-4184
Address
100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR, FLORHAM PARK, NY
Compare BYSI vs VRTX, REGN, MRNA, ARGX, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BYSI
Beyondspring Inc
|
0.7772 | 31.96M | 1.88M | -8.48M | -19.13M | -0.1881 |
VRTX
Vertex Pharmaceuticals Inc
|
526.19 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
788.04 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
198.88 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
959.49 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
204.97 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Beyondspring Inc Stock (BYSI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-21 | Downgrade | BofA Securities | Buy → Underperform |
| Dec-02-21 | Downgrade | Jefferies | Buy → Hold |
| Dec-01-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Dec-01-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Sep-09-21 | Initiated | Robert W. Baird | Outperform |
| Aug-04-21 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Apr-05-21 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jan-11-21 | Initiated | BofA Securities | Buy |
| Dec-29-20 | Initiated | Evercore ISI | Outperform |
| Feb-07-20 | Initiated | Jefferies | Buy |
| Jan-10-20 | Initiated | Nomura | Buy |
| Dec-03-19 | Initiated | William Blair | Outperform |
| Jul-10-19 | Reiterated | H.C. Wainwright | Buy |
| Apr-30-19 | Downgrade | Maxim Group | Buy → Hold |
| Oct-25-18 | Reiterated | Maxim Group | Buy |
View All
Beyondspring Inc Stock (BYSI) Latest News
Beyondspring Inc (BYSI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Premarket movers: GRML and BTTC lead gainers, IMCC and DLXY lead losers - ChartMill
Beyondspring Stock Price Forecast. Should You Buy BYSI? - StockInvest.us
BeyondSpring Faces Nasdaq Noncompliance Over Minimum Bid Price - TipRanks
BeyondSpring Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
BeyondSpring (BYSI): Plinabulin Advances While the Balance Sheet Reaches a Critical Threshold - AlphaStreet
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
BeyondSpring (NASDAQ: BYSI) Announces 2026 Annual General Meeting with Virtual Access - kalkinemedia.com
BeyondSpring Inc. SEC Filing (Sep 3, 2026) - stocktitan.net
BeyondSpring (BYSI) plans Oct. 13 vote on 2026 auditor - stocktitan.net
Intelligent Bio Solutions Raises Up to $15M in Private Placement - Minichart
BeyondSpring (BYSI) EPS and Revenue: The Company Lists Its Latest Available Figures for This Review; Stock Move: The Stock Records a Flat Reaction in the Current UpdateAnalyst Coverage Count - vinanet.vn
BeyondSpring (BYSI) Results Versus Estimates: Available Data Shows the Latest Reported Performance in Latest Trading; Market Reaction: Shares Close 0.28% Lower in the Current UpdatePositive Surprise Momentum - vinanet.vn
BeyondSpring (BYSI) Range: Adds 4.89% to Close at $0.75 in the Current Update; Market Levels: the Supplied Trading Band Runs From $0.71 to $0.79 in the Latest SessionSMA Signal - vinanet.vn
BeyondSpring Inc. (BYSI) Reports Q2 Loss of $0.02 - StreetInsider
BeyondSpring (BYSI) Q2 Results Highlight Challenges Amid High Price-to-Sales Valuation - GuruFocus
BeyondSpring (BYSI) Slides 15.78% to $0.84 as Key Support NearsValue Area High - vinanet.vn
BYSI Q1 2026 Earnings: Net Loss Per Share of $0.05 Reported as Shares Slide 15.78%Investor Earnings Call - vinanet.vn
BeyondSpring (BYSI) Plunges 15.78% to $0.84 as Key Support at $0.80 Comes into FocusMax Pain Level - siam.in
BeyondSpring Reports Second-Quarter 2026 Financial Results and Provides Corporate Update - manilatimes.net
BeyondSpring Cash Drops to $6.4M, Escalating Going-Concern Risk - minichart.com.sg
BeyondSpring Cash Drops to $6.5M as DUBLIN-4 Trial Funding Looms - Minichart
BeyondSpring Q2 loss narrows to $849k; EPS improves to $(0.02) - scanx.trade
BeyondSpring Inc. (BYSI) founders disclose 5.29M shares each in 13G/A - Stock Titan
BYSI: Net loss increased to $5.7M in Q2 2026, with urgent need for new funding amid ongoing R&D - TradingView
BeyondSpring (BYSI) posts deeper H1 2026 loss and flags going concern risk - Stock Titan
BeyondSpring Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
BeyondSpring Posts $5.7 Million Second-Quarter Net Loss - Quiver Quantitative
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
BYSI Q1 2026 Earnings: Loss Per Share of $0.05 Reported as Shares Rise 7.01%Earnings Call Transcript - vinanet.vn
Beyondspring Inc (BYSI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Vascular Disrupting Agents Market - Future Market Insights
Beyondspring Inc (BYSI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BeyondSpring Inc. (BYSI) Q1 2026 Earnings: Pre-Revenue Biotech Reports Narrowed Loss Amid Pipeline ProgressShort-Term Outlook - dars.gov.et
BYSI Q1 2026 Earnings: Narrowed Loss Reflects Continued Clinical ProgressEarnings Outlook Update - vinanet.vn
Beyondspring Inc (BYSI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
BYSI|Beyondspring Inc|Price:0.720|Chg%:-0.002 - TradingKey
Beyondspring Inc (BYSI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Beyondspring Inc (BYSI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Beyondspring Inc (BYSI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
BYSI Q1 2026 Earnings: EPS Loss of $0.05 Reported; Shares Rise 3.7%Earnings Turnaround - vinanet.vn
Beyondspring Inc (BYSI) Income Statement - TradingKey
BYSI|Beyondspring Inc|Price:0.717|Chg%:+0.005 - TradingKey
Beyondspring Inc (BYSI) Valuation: PE, PB & Fair Value Analysis - TradingKey
BYSI|Beyondspring Inc|Price:0.775|Chg%:+0.033 - TradingKey
BeyondSpring, Inc. Revenue Breakdown – NASDAQ:BYSI - TradingView
BYSI|Beyondspring Inc|Price:1.120|Chg%:+0.040 - TradingKey
BeyondSpring (BYSI) Advances 6.94% as Shares Test Key Resistance LevelsEase of Movement - careplusvn.com
BYSI Q1 2026 Earnings: Loss Narrows to $0.05 per Share as Pipeline AdvancesNet Profit Margin - dars.gov.et
Na (nl) Li Net Worth (2026) - GuruFocus
Min Qiu Net Worth (2026) - GuruFocus
Beyondspring Inc Stock (BYSI) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.06%
2.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):